サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1325032

陽子線治療の世界市場

Proton Therapy
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
陽子線治療の世界市場
出版日: 2023年08月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

陽子線治療の世界市場は2030年までに13億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に4億8,510万米ドルと推定される陽子線治療の世界市場は、2030年には13億米ドルに達すると予測され、2022年から2030年にかけて13.4%のCAGRで成長すると予測されます。本レポートで分析されているセグメントの一つである加速器は、CAGR13.6%を記録し、分析期間終了時には7億5,880万米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、ビームデリバリーシステム分野の成長は今後8年間のCAGRを14.1％に修正しました。

米国市場は1億4,370万米ドル、中国はCAGR 12.5％で成長すると予測

米国の陽子線治療市場は、2022年には1億4,370万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR12.5%で、2030年までに2億2,380万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ12%と11.4%の成長が予測されています。欧州では、ドイツがCAGR約9.6%で成長すると予測されています。

調査対象企業の例

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP14268

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Proton Therapy Market to Reach $1.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Proton Therapy estimated at US$485.1 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at aCAGR of 13.4% over the period 2022-2030. Accelerators, one of the segments analyzed in the report, is projected to record 13.6% CAGR and reach US$758.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Beam Delivery Systems segment is readjusted to a revised 14.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $143.7 Million, While China is Forecast to Grow at 12.5% CAGR

The Proton Therapy market in the U.S. is estimated at US$143.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$223.8 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Select Competitors (Total 43 Featured) -

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Proton Therapy - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Proton Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Accelerators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Beam Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Beam Transport Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for CNS Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Head & Neck Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Proton Therapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: China 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: France 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2023 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2023 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION